Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Dentsply Sirona Earnings: What To Look For From XRAY
Dentsply Sirona Earnings: What To Look For From XRAY
Dentsply Sirona Earnings: What To Look For From XRAY
Anthony Lee
Thu, February 26, 2026 at 12:51 AM GMT+9 2 min read
In this article:
XRAY
-3.39%
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting earnings tomorrow after the bell. Here’s what to look for.
Dentsply Sirona beat analysts’ revenue expectations last quarter, reporting revenues of $904 million, down 4.9% year on year. It was a softer quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates and a significant miss of analysts’ EPS estimates.
Is Dentsply Sirona a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Dentsply Sirona’s revenue to grow 1.9% year on year, a reversal from the 10.6% decrease it recorded in the same quarter last year.
Dentsply Sirona Total Revenue
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Dentsply Sirona has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Dentsply Sirona’s peers in the dental equipment & technology segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Envista delivered year-on-year revenue growth of 15%, beating analysts’ expectations by 10.6%, and Henry Schein reported revenues up 7.7%, topping estimates by 2.8%. Envista traded up 17.8% following the results.
Read our full analysis of Envista’s results here and Henry Schein’s results here.
Investors in the dental equipment & technology segment have had fairly steady hands going into earnings, with share prices down 1.9% on average over the last month. Dentsply Sirona is up 3.3% during the same time and is heading into earnings with an average analyst price target of $13.23 (compared to the current share price of $13.20).
Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Terms and Privacy Policy
Privacy Dashboard
More Info